DENTSPLY International Inc. Stock Downgraded (XRAY)
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. NEW YORK (TheStreet) -- DENTSPLY International (Nasdaq:XRAY) has been downgraded by TheStreet Ratings from buy to hold. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in stock price during the past year and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and generally higher debt management risk.
- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
- The revenue growth came in higher than the industry average of 4.2%. Since the same quarter one year prior, revenues rose by 12.3%. This growth in revenue does not appear to have trickled down to the company's bottom line, displayed by a decline in earnings per share.
- Compared to where it was 12 months ago, the stock is up, but it has so far lagged the appreciation in the S&P 500. Despite the fact that it has already risen in the past year, there is currently no conclusive evidence that warrants the purchase or sale of this stock.
- The gross profit margin for DENTSPLY INTERNATL INC is rather high; currently it is at 52.30%. Regardless of XRAY's high profit margin, it has managed to decrease from the same period last year. Despite the mixed results of the gross profit margin, XRAY's net profit margin of 7.70% is significantly lower than the same period one year prior.
- The company's current return on equity has slightly decreased from the same quarter one year prior. This implies a minor weakness in the organization. When compared to other companies in the Health Care Equipment & Supplies industry and the overall market, DENTSPLY INTERNATL INC's return on equity is below that of both the industry average and the S&P 500.
- The company, on the basis of change in net income from the same quarter one year ago, has underperformed when compared to that of the S&P 500 and the Health Care Equipment & Supplies industry average. The net income has decreased by 11.9% when compared to the same quarter one year ago, dropping from $60.60 million to $53.36 million.
-- Written by a member of TheStreet Ratings Staff
FREE from Real Money's Jim Cramer: Winners and Losers Election 2012 - Steps to take NOW so you can profit no matter who is in charge! Free download now.
Latest Headlines about XRAY
-
The New #5 Most Shorted S&P 500 Component: DENTSPLY International
03:13PM 05/10/13
-
4 Buys Near 52-Week Highs
01:42PM 05/09/13
-
DENTSPLY International's CEO Discusses Q2 2012 Results - Earnings Call Transcript
04:13PM 07/31/12
-
DENTSPLY International's CEO Discusses 1Q 2012 Results - Earnings Call Transcript
04:24PM 05/01/12
-
Dentsply International's CEO Discusses Q4 2011 Results - Earnings Call Transcript
01:05PM 02/16/12
-
5 Investment Ideas From Wall Street: Jan. 31
09:39AM 01/31/12
-
Insiders Trading ZIOP, DEI, PCYC, XRAY
09:10AM 01/24/12
Latest from TheStreet Wire
-
5 Stocks Pushing The Insurance Industry Downward
01:03PM 06/19/13
-
4 Stocks Dragging The Specialty Retail Industry Downward
01:03PM 06/19/13
-
SNE, CL And KMB, Pushing Consumer Goods Sector Downward
01:03PM 06/19/13
-
5 Stocks Pulling The Industrial Industry Downward
01:03PM 06/19/13
-
4 Computer Software & Services Stocks Dragging The Industry Down
01:03PM 06/19/13
-
CSX, CMG, WFM, UNP And TGT, 5 Services Stocks Pushing The Sector Lower
01:03PM 06/19/13
-
A, TSM, GLW, BRCM And FSLR, Pushing Electronics Industry Downward
01:03PM 06/19/13
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
